-
In re: Fenofibrate Patent Litigation DC CAFC
- 1:11-md-02241
- S.D.N.Y.
- Judge: Jed Saul Rakoff
- Filed: 05/23/2011
- Closed: 12/28/2012
- Latest Docket Entry: 09/26/2013
- PACER
- Docket updated daily
2
Plaintiffs
6
Defendants
0
Accused
Products
2
Patents-in-Suit
586
Days in
Litigation
-
In re: Fenofibrate Patent Litigation DC CAFC
- 1:11-md-02241
- S.D.N.Y.
- Judge: Jed Saul Rakoff
- Filed: 05/23/2011
- Closed: 12/28/2012
- Latest Docket Entry: 09/26/2013
- PACER
- Docket updated daily
Complaint Unavailable
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Apotex Corporation
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivativeTwo generic dosage of of Antara, 43mg 43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,101,574 B1 | All Asserted Claims |
No infringement
Entry 117
|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivativeTwo generic dosage of of Antara, 43mg 43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 117
|
Apotex Inc.
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivativeTwo generic dosage of of Antara, 43mg 43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,101,574 B1 | All Asserted Claims |
No infringement
Entry 117
|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivativeTwo generic dosage of of Antara, 43mg 43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 117
|
Mylan Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivative43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,101,574 B1 | All Asserted Claims |
No infringement
Entry 117
|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivative43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 117
|
Mylan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivative43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,101,574 B1 | All Asserted Claims |
No infringement
Entry 117
|
| 130 mg of fenofibrate, 27.7 mg of binding cellulose derivative43 mg of fenofibrate, 9.16 mg of binding cellulose derivate | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 117
|
